Tandem Diabetes Care's share price rise sparks hope, but tur...
Tandem Diabetes Care's share price rise sparks hope, but turnarounds can be risky. The gap between revenue and share price growth could warrant further investigation. Last year's performance suggests unresolved issues, as it underperformed the annualised 10% loss over the past five years.
Investors Are Selling off Tandem Diabetes Care (NASDAQ:TNDM), Lack of Profits No Doubt Contribute to Shareholders Three-year Loss
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment